Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study on the Influencing Factors of the Efficacy of Ruxolitinib Cream in the Treatment of Vitiligo

NCT07153666 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07153666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07153666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study on the Influencing Factors of the Efficacy of Ruxolitinib Cream in the Treatment of Vitiligo
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 8, 2025
Completion date
December 31, 2027
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo